ANNOUNCEMENT

Save $300 on MedCity CONVERGE Healthcare Innovation Summit July 9-10 in Philadelphia. Earlybird rate ends May 20.

Topic: Hatteras Venture Partners

Seed round will help radiation therapy startup prevent harmful effects of chemotherapy

Seed round will help radiation therapy startup prevent harmful effects of chemotherapy

October 16, 2012 2:48 pm by | 0 Comments

One of the most common and most disruptive drawbacks of existing cancer chemotherapies is the toxic effect of bone marrow suppression that can result from a patient’s exposure to ionized ... Read more
Hatteras Ventures will invest up to $30M into ‘Discovery’

Hatteras Ventures will invest up to $30M into ‘Discovery’

May 13, 2011 5:56 pm by | 0 Comments

North Carolina venture capital firm Hatteras Venture Partners will use about 20 percent of an estimated $100 million to $150 million fourth fund to invest in seed-stage opportunities.The early stage ... Read more
N.C. pharma IT firm ArtusLabs bought by PerkinElmer; pair of deals total $220M

N.C. pharma IT firm ArtusLabs bought by PerkinElmer; pair of deals total $220M

March 24, 2011 1:07 pm by | 0 Comments

R&D software company ArtusLabs has been acquired by life science and health IT company PerkinElmer (NYSE:PKI) as one of a pair of deals intended to boost the Massachusetts company’s offerings ... Read more
Diabetes, cardiovascular drug developer PhaseBio adds $15M

Diabetes, cardiovascular drug developer PhaseBio adds $15M

December 3, 2010 9:37 am by | 0 Comments

The Philadelphia-area pharmaceutical company hopes for medical breakthroughs in Type 2 diabetes and hypertension. PhaseBio has embarked on Phase I and Phase II testing of its diabetes treatment, Glymera. Another ... Read more